Health explains modification to the vaccination plan and how the booster would be for those vaccinated with Johnson & Johnson – Prensa Libre

On Wednesday, December 1, the Ministry of Health published in the Central American newspaper the second modification to the National Vaccination Plan against covid-19 in Guatemala.

In that sense, Eliú Mazariegos, director of the Comprehensive Health Care System, explained this Thursday that this second modification mainly involves the issue of vaccinating pregnant women over 18 years of age, for example with the Pfizer or AstraZeneca vaccine.

In pregnant women under 18 years of age, with Pfizer and Moderna vaccines.

It also includes the issue of vaccination of 12 to 17 years with doses of Pfizer and Moderna.

The modification contemplates that for now the booster vaccine or additional dose against covid-19 is specifically for people over 60 years of age and for first-line health personnel.

Also for people who have a heart disease, a tumor or an immunodeficiency.

Mazariegos recalled that what is important about the booster dose is that six months have passed since the second dose of Pfizer, Moderna, Sputnik V and AstraZeneca.

He said that in the case of people who are administered Johnson & Johnson, it is two months later that they can be administered Pfizer, Moderna or AstraZeneca.

Guatemalans have to present a card to prove that the six months have passed and there is no need to register in the system.

Must register

Those who were administered Johnson & Johnson abroad or one of Sinovac for example, first have to register on the platform of the Ministry of Health and the system will recognize them as the first dose.

Read also: HPV vaccine doses are scarce in the capital due to high demand, in the province the process has not started

He added that training was given to staff staying in the health areas so that they know what changes were made in the system, which is now enabled to record booster doses.

According to the data, 123 thousand people can already apply their booster doses, this figure is for the general population, but they will start with priority groups.

Mazariegos explained that they have not foreseen that Sputnik V will be the reinforcement for Johnson & Johnson, but in a recent press conference they indicated that it is.

He added that Sputnik V booster could be AstraZeneca and even Pfizer or Moderna.

For people who took the Sinovac dose, the booster can be with Pfizer, Moderna, or AstraZeneca.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.